Scottish biopharma company’s state-of-the-art technology attracts £730k in fresh investment
Scottish biopharmaceutical company Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding aimed at further developing its state-of-the-art therapeutic and diagnostic technology and setting up fresh success in 2024.The funding round – which will be split across two tranches – has been supported by new and existing … Read more